Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937597/
WebMar 7, 2021 · The development of cancer immunotherapies, harnessing the immune system to restore anti-tumor immunity, has transformed the treatment of certain cancers. The first immune checkpoint inhibitor (ICI), an antibody targeting the cytotoxic T lymphocyte antigen 4 (CTLA4), was approved by the Food and Drug Administration in 2011 (1, 2).
DA: 65 PA: 56 MOZ Rank: 71